Report Cover

Global Biopharmaceutical CMO Market – Analysis By Product Type (Microbial, Others), By Region, By Country (2020 Edition): Opportunities and Forecast (2020-2025) - By Region (N. America, Europe, APAC), By Country (US, Germany, Switzerland, Denmark, China, Japan, South Korea)

Limited Time Offer

Executive Summary

Global Biopharmaceutical CMO Market was valued at USD 13296.29 million in the year 2019. Escalating number of patients suffering from various diseases with growing investment in the healthcare industry by government in major economies and increasing awareness among consumers regarding impact of various viruses on health, has been anticipated to infuse growth in the market for Biopharmaceutical CMO during the forecasting period of 2020-2025.

Under the product segment, Others is anticipated to witness a substantial market share owing to growing partnership among various pharmaceutical companies and leading CMOs which are helping in providing medicines, biologics delivery with advanced technology and efficient labour force backed with enhanced investment in expanding geographically, will be accelerating the Biopharmaceutical CMO market growth in the coming years.
Among the regions, Europe, followed by North America and Asia Pacific, will experience remarkable market share owing to presence of major countries including United Kingdom, Norway, Denmark, Switzerland that feature efficient healthcare system supported by ever growing number of patients. Rising need of developing medicine for many viruses coupled with growing mergers and acquisitions in the region between pharma companies and CMOs, will be propelling the Biopharmaceutical CMO market growth during the period of 2020-2025.

Scope of the Report

• The report analyses Biopharmaceutical CMO market By Value.
• The report analyses Biopharmaceutical CMO Market By Product Type (Microbial, and Others). 
• The Global Biopharmaceutical CMO Market has been analysed By Region (North America, Europe, and Asia Pacific) and By Country (United States, Germany, Switzerland, Denmark, China, Japan, South Korea). 
• The key insights of the report have been presented through the frameworks of Major mergers and acquisitions. Also, the attractiveness of the market has been presented By Region, and By Product Type. Additionally, the major opportunities, SWOT analysis, trends, drivers and challenges of the industry has been analysed in the report. 
• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Wuxi Biologics, Boehringer Ingelheim, Lonza, Samsung Biologics. 
• The report presents the analysis of Biopharmaceutical CMO market for the historical period of 2015-2019 and the forecast period of 2020-2025.

Key Target Audience

• Biopharmaceutical CMO Vendors
• Pharmaceutical Companies
• Pharmaceutical Manufacturers
• Consulting and Advisory Firms
• Investment Banks and Equity Firms
Table of Contents

1. Research Methodology and Executive Summary
1.1 Research Methodology
1.2 Executive Summary

2. Strategic Recommendations
2.1 Focus on Providing Quality and Reliability
2.2 Focus on Investing in Internal Factors

3. Biopharmaceutical CMO Market : Product Outlook

4. Global Biopharmaceutical CMO Market: Sizing and Forecast
4.1 Market Size, By Value, Year 2015-2025

5. Global Biopharmaceutical CMO Market Segmentation - By Product Type
5.1  Competitive Scenario of Global Biopharmaceutical CMO Market: By Product Type
5.1.1 Microbial – Market Size and Forecast (2015-2025)
5.1.2 Others – Market Size and Forecast (2015-2025)

6. Global Biopharmaceutical CMO Market: Regional Analysis
6.1  Competitive Scenario of Global Biopharmaceutical CMO Market : By Region

7. North America Biopharmaceutical CMO Market: Segmentation By Product Type (2015-2025)
7.1 North America Biopharmaceutical CMO Market: Size and Forecast (2015-2025), By Value
7.2 Market Segmentation By Product Type (Microbial, and Others)
7.3 North America Biopharmaceutical CMO Market: Country Analysis
7.5 Market Opportunity Chart of North America Biopharmaceutical CMO Market - By Country, By Value, 2025
7.6 Competitive Scenario of North America Biopharmaceutical CMO Market : By Country
7.7 United States Biopharmaceutical CMO Market: Size and Forecast (2015-2025), By Value
7.8 United States Biopharmaceutical CMO Market Segmentation - By Product Type

8. Europe Biopharmaceutical CMO Market: Segmentation By Product Type (2015-2025)
8.1 Europe Biopharmaceutical CMO Market: Size and Forecast (2015-2025), By Value
8.2 Market Segmentation By Product Type (Microbial, and Others)
8.3 Europe Biopharmaceutical CMO Market: Country Analysis
8.4 Market Opportunity Chart of Europe Biopharmaceutical CMO Market - By Country, By Value, 2025
8.5 Competitive Scenario of Europe Biopharmaceutical CMO Market : By Country
8.6 Germany Biopharmaceutical CMO Market: Size and Forecast (2015-2025), By Value
8.7 Germany Biopharmaceutical CMO Market Segmentation - By Product Type
8.8 Switzerland Biopharmaceutical CMO Market: Size and Forecast (2015-2025), By Value
8.9 Switzerland Biopharmaceutical CMO Market Segmentation - By Product Type
8.10 Denmark Biopharmaceutical CMO Market: Size and Forecast (2015-2025), By Value
8.11 Denmark Biopharmaceutical CMO Market Segmentation - By Product Type

9. Asia Pacific Biopharmaceutical CMO Market: Segmentation By Product Type (2015-2025)
9.1 Asia Pacific Biopharmaceutical CMO Market: Size and Forecast (2015-2025), By Value
9.2 Market Segmentation By Product Type (Microbial, and Others)
9.3 Asia Pacific Biopharmaceutical CMO Market: Country Analysis
9.4 Market Opportunity Chart of Asia Pacific Biopharmaceutical CMO Market - By Country, By Value, 2025
9.5 Competitive Scenario of Asia Pacific Biopharmaceutical CMO Market : By Country
9.6 China Biopharmaceutical CMO Market: Size and Forecast (2015-2025), By Value
9.7 China Biopharmaceutical CMO Market Segmentation - By Product Type
9.8 Japan Biopharmaceutical CMO Market: Size and Forecast (2015-2025), By Value
9.9 Japan Biopharmaceutical CMO Market Segmentation - By Product Type
9.10 South Korea Biopharmaceutical CMO Market: Size and Forecast (2015-2025), By Value
9.11 South Korea Biopharmaceutical CMO Market Segmentation - By Product Type

10. Global Biopharmaceutical CMO Market Dynamics
10.1 Drivers
10.2 Restraints
10.3 Trends

11. Market Attractiveness
11.1 Market Attractiveness Chart of Global Biopharmaceutical CMO Market - By Product Type, 2025
11.3 Market Attractiveness Chart of Global Biopharmaceutical CMO Market - By Region, 2025

12. Strategic Analysis and Competitive Landscape
12.1 SWOT Analysis
12.2 Major Technological Innovations and Mergers & Acquisitions
12.3 Market Share Analysis

13. Company Analysis
13.1 Lonza
13.2 Boehringer Ingelheim
13.3 Samsung Biologics
13.4 Wuxi Biologics

List of Figures Figure 1: Global Bio CMO Market Size, By Value, 2015-2025 (USD Million) Figure 2: Global Biologics market Outlook, 2012, 2016, 2021 (In Billion ) Figure 3: Global Biologics market Outlook, By Countries, 2019 (In Billion) Figure 4: Global Healthcare Expenditure, 2012-2016 (In Trillion) Figure 5: Global Biopharmaceutical CMO Market, By Product Type, 2019, 2025 Figure 6: Global Biopharmaceutical CMO Market - By Microbial, By Value (USD Million), 2015-2025 Figure 7: Global Biopharmaceutical CMO Market - By Others, By Value (USD Million), 2015-2025 Figure 8: Global Biopharmaceutical CMO Market, By Region, 2019, 2025 Figure 9: North America Biopharmaceutical CMO Market Size, By Value, 2015-2025 (USD Million) Figure 10: North America GDP, 2014-2017 (USD Trillion) Figure 11: North America GDP, By Select Country, 2018 (USD Trillion) Figure 12: North America Healthcare Cost Per Capita, By Select Country, 2018 (USD) Figure 13: Number of Citizen 65 years and above, USA and Canada in Million 2018 Figure 14: Number of Citizen 65 years and above, USA and Canada in Million 2060 Figure 15: North America Prevalence of Gynecological Disorders (2014-2016) Figure 16: Total Number of People with North America Neglected Tropical Disorders (2014-2016) Figure 17: Total Number of People in North America with Different Type of Cardiovascular Disease in 2018 Figure 18: North America DALYs of Ischemic Heart Disease (2014-2016 %) Figure 19: North America DALYs of Chronic Kidney Disease (2014-2017 %) Figure 20: North America DALYs of Chronic Obstructive Pulmonary Disease (2014-2017 %) Figure 21: North America DALYs of Alzheimer Disease and Other Dementias (2014-2017 %) Figure 22: North America DALYs of Diabetes Mellitus (2014-2017 %) Figure 23: North America Biopharmaceutical CMO Market - By Product Type, By Value, 2015-2025 (USD Million) Figure 24: Market Opportunity Chart of North America Biopharmaceutical CMO Market - By Country, By Value, 2025 Figure 25: North America Biopharmaceutical CMO Market, By Country, 2019, 2025 Figure 26: United States Biopharmaceutical CMO Market Size, By Value, 2015-2025 (USD Million) Figure 27: United States Prevalence of Diabetes (Per 1,00,000 )2014-2017 Figure 28: United States Prevalence of Musculoskeletal Disorders (Per 1,00,000 )2014-2017 Figure 29: Prevalence of Neurological Disorders in United States (2016, Million) Figure 30: United States Prevalence of Cardiovascular Disorders (Per 1,00,000) 2014-2017 Figure 31: United States DALYs of Ischemic Heart Disease (2014-2017 %) Figure 32: United States DALYs of Chronic Kidney Disease(2014-2017 %) Figure 33: United States DALYs of Chronic Obstructive Pulmonary Disease(2014-2017 %) Figure 34: United States DALYs of Alzheimer Disease and Other Dementias (2014-2017 %) Figure 35: United States DALYs of Diabetes Mellitus (2014-2017 %) Figure 36: United States Biopharmaceutical CMO Market - By Product Type, By Value, 2015-2025 (USD Million) Figure 37: Europe Biopharmaceutical CMO Market Size, By Value, 2015-2025 (USD Million) Figure 38: Number Of Deaths due to cancer in Europe, 2017 Figure 39: Share of older population 65 years and above as percentage of total population, 2017 Figure 40: Europe Prevalence of Gynecological (2014-2017, Million) Figure 41: Europe Prevalence of Musculoskeletal Disorders (2014-2017, Million) Figure 42: Total Number of People With Cardiovascular Disorders in Europe, By Type, 2017 Figure 43: Europe DALYs of Ischemic Heart Disease (2014-2017), in % Figure 44: Europe DALYs of Chronic Kidney Disease(2014-2017)in % Figure 45: Europe DALYs of Chronic Obstructive Pulmonary Disease(2014-2017 %) Figure 46: Europe DALYs of Alzheimer Disease and Other Dementias (2014-2017 )in % Figure 47: Europe DALYs of Diabetes Mellitus (2014-2017 )in % Figure 48: Europe Biopharmaceutical CMO Market - By Product Type, By Value, 2015-2025 (USD Million) Figure 49: Market Opportunity Chart of Europe Biopharmaceutical CMO Market - By Country, By Value, 2025 Figure 50: Europe Biopharmaceutical CMO Market, By Country, 2019, 2025 Figure 51: Germany Biopharmaceutical CMO Market Size, By Value, 2015-2025 (USD Million) Figure 52: Germany DALYs of Ischemic Heart Disease (2014-2017), in % Figure 53: Germany DALYs of Chronic Kidney Disease (2014-2017), in % Figure 54: Germany DALYs of Chronic Obstructive Pulmonary Disease(2014-2017), in% Figure 55: Germany DALYs of Alzheimer Disease and Other Dementias (2014-2017), % Figure 56: Germany DALYs of Diabetes Mellitus (2014-2017), % Figure 57: Germany Biopharmaceutical CMO Market - By Product Type, By Value, 2015-2025 (USD Million) Figure 58: Switzerland Biopharmaceutical CMO Market Size, By Value, 2015-2025 (USD Million) Figure 59: Switzerland Prevalence of Musculoskeletal Disorders (In Millions), 2014-2017 Figure 60: Total Number of People With Infectious Disorder in Switzerland (2014-2017), In thousands Figure 61: Switzerland Prevalence of Neurological Disorders (2014-2017, Million) Figure 62: Switzerland Prevalence of Cardiovascular Disorders, 2014-2017 (In Millions) Figure 63: Switzerland Biopharmaceutical CMO Market - By Product Type, By Value, 2015-2025 (USD Million) Figure 64: Denmark Biopharmaceutical CMO Market Size, By Value, 2015-2025 (USD Million) Figure 65: Denmark Prevalence of Musculoskeletal Disorders (In Millions), 2014-2017 Figure 66: Total Number of People With Infectious Disorder in Denmark (2014-2017), In thousands Figure 67: Denmark Prevalence of Neurological Disorders (2014-2017, Million) Figure 68: Denmark Prevalence of Cardiovascular Disorders, 2014-2017 (In Millions) Figure 69: Denmark Biopharmaceutical CMO Market - By Product Type, By Value, 2015-2025 (USD Million) Figure 70: Asia Pacific Biopharmaceutical CMO Market Size, By Value, 2015-2025 (USD Million) Figure 71: Asia, East Asia, Oceania , DALYs of Ischemic Heart Disease (2014-2017 %) Figure 72: Asia, East Asia, Oceania DALYs of Chronic Kidney Disease(2014-2017 %) Figure 73: Asia, East Asia, Oceania DALYs of Chronic Obstructive Pulmonary Disease(2014-2017 %) Figure 74: Asia, East Asia, Oceania DALYs of Alzheimer Disease and Other Dementias (2014-2017 %) Figure 75: Asia, East Asia, Oceania DALYs of Diabetes Mellitus (2014-2017 %) Figure 76: Asia Pacific Biopharmaceutical CMO Market - By Product Type, By Value, 2015-2025 (USD Million) Figure 77: Market Opportunity Chart of Asia Pacific Biopharmaceutical CMO Market - By Country, By Value, 2025 Figure 78: Asia Pacific Biopharmaceutical CMO Market, By Country, 2019, 2025 Figure 79: China Biopharmaceutical CMO Market Size, By Value, 2015-2025 (USD Million) Figure 80: China DALYs of Ischemic Heart Disease (2014-2017 %) Figure 81: China DALYs of Chronic Kidney Disease(2014-2017 %) Figure 82: China DALYs of Chronic Obstructive Pulmonary Disease(2014-2017 %) Figure 83: China DALYs of Alzheimer Disease and Other Dementias (2014-2017 %) Figure 84: China DALYs of Diabetes Mellitus (2014-2017 %) Figure 85: China Biopharmaceutical CMO Market - By Product Type, By Value, 2015-2025 (USD Million) Figure 86: Japan Biopharmaceutical CMO Market Size, By Value, 2015-2025 (USD Million) Figure 87: Japan DALYs of Ischemic Heart Disease (2014-2017 %) Figure 88: Japan DALYs of Chronic Kidney Disease(2014-2017 %) Figure 89: Japan DALYs of Chronic Obstructive Pulmonary Disease(2014-2017 %) Figure 90: Japan DALYs of Alzheimer Disease and Other Dementias (2014-2017 %) Figure 91: Japan DALYs of Diabetes Mellitus(2014-2017 %) Figure 92: Japan Biopharmaceutical CMO Market - By Product Type, By Value, 2015-2025 (USD Million) Figure 93: South Korea Biopharmaceutical CMO Market Size, By Value, 2015-2025 (USD Million) Figure 94: South Korea Prevalence of Musculoskeletal Disorders (In Millions), 2014-2017 Figure 95: Total Number of People With Infectious Disorder in South Korea (2014-2017), In thousands Figure 96: South Korea Prevalence of Neurological Disorders (2014-2017, Million) Figure 97: South Korea Prevalence of Cardiovascular Disorders, 2014-2017 (In Millions) Figure 98: South Korea Biopharmaceutical CMO Market - By Product Type, By Value, 2015-2025 (USD Million) Figure 99: Market Attractiveness Chart of Global Biopharmaceutical CMO Market - By Product Type, 2025 Figure 100: Market Attractiveness Chart of Global Biopharmaceutical CMO Market - By Region, By Value, 2025 Figure 101: Market Share of Leading Global Biopharmaceutical CMO Companies, 2019 (In %) Figure 102: Lonza, Net Sales, 2014-2017 (In Billion USD) Figure 103: Boehringer Ingelheim, Net Sales, 2014-2016 (In Million USD) Figure 104: Boehringer Ingelheim Sales by Region, 2016 Figure 105: Boehringer Ingelheim Sales by Segment, 2016Boehringer Ingelheim Sales by Segment, 2016 Figure 106: Samsung Biologics, Net Sales, 2014-2018 (In Million USD) Figure 107: Samsung Biologics, Biomedicine manufacturing plants, 2017 Figure 108: Wuxi Biologics, Net Sales, 2014 - 2018 (In Million USD) Figure 109: Wuxi Biologics, Sales by Region, 2018 Figure 110: Wuxi Biologics Sales by Region, 2017 List of Tables Table A: A Brief Comparison Between Chemicals and Biologics Table B: Number of people with diabetes worldwide and per region in 2017 and 2045, (20-79 years) Table C: Diabetes Prevalence, By Country, in % of population ages 20 to 79 in 2017

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

New Pharmaceuticals and Healthcare Reports

Internal Neuromodulation Market Forecast 2025 | Global Report

Rising number of patients suffering from neurological disorders such as Parkinson’s, essential tremor, and primary dystonia is fueling the demand for internal neuromodulation procedures. Chronic back and leg pain associated with PVD (peripheral...

Gastrointestinal Cancer Treatment Market Size 2020-2025 | Growth Forecasts

As per credible projections, gastrointestinal cancer treatment industry is expected to register strong CAGR over 2019-2025. Rising adoption of unhealthy eating habits and increasing consumption of tobacco and alcohol have increased the pervasiveness ...

Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, ...

Flu Vaccine Market Share 2020-2025 | Global Industry Report

As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy o...

Healthcare Linen Market Size - Industry Trends Report 2025

According to reliable projections, global healthcare linen market is projected to record considerable growth during 2020-2025. Rising prevalence of various diseases including cardiovascular diseases, cancer, and arthritis along with increasing cases ...

Other Reports by Azoth Analytics

Global Duodenoscope Market - Analysis By Type, By Treatment, By Region, By Country (2020 Edition): Market Insights and Outlook Post Covid-19 Pandemic (2020-2025)

Executive Summary Global Duodenoscope Market was valued at USD 151.23 million in the year 2019. Rising prevalence of life threatening diseases such as pancreatitis, gall bladder and biliary diseases, pancreatic cancer due to obesity, smoking & other...

Global Medical Waste Market - Analysis By Product Type, By End User, By Region, By Country (2020 Edition): Market Insights and Outlook Post Covid-19 Pandemic (2020-2025)

Executive Summary According to new research report, the Global Medical Waste market is projected to display a robust growth represented by a CAGR of 2.63% during 2020-2025. Global Medical Waste Market was valued at USD 29.09 billion in the year 2019...

Global Biodegradable Plastics Market (Value, Volume) - Analysis By Product, Application, By Region, By Country (2020 Edition): Market Insights and Outlook Post Covid-19 Pandemic (2020-2025)

Executive Summary The Global Biodegradable Plastics Market, valued at USD 4709.19 Million and x thousand tonnes by volume in the year 2019 has been witnessing unprecedented growth. Growth opportunities in biodegradable plastics market is promising b...

Global High Temperature Pressure Transmitter Market: Analysis By Product Type (Intrinsic, Extrinsic), End User, By Region, By Country (2020 Edition): Market Insights and Outlook Post Covid-19 Pandemic (2020-2025)

Executive Summary The Global High Temperature Pressure Transmitters Market was valued at USD 619.23 Million in the year 2019. These devices are utilized in applications where multiple variables need to measured. The goal of such high temperature pre...

Global Toy Market - Analysis By Product Type, By Age, By Distribution Channel, By Region, By Country (2020 Edition): Market Insights and Outlook Post Covid-19 Pandemic (2020-2025)

Executive Summary The Covid-19 pandemic has a minimal impact on the global toy industry despite the supply chain disruptions and closure of retail outlets as the e-commerce channel facilitated the growth of the market. The pandemic resulted in closu...

Publisher: Azoth Analytics
Chat with us